A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2011
11/17/2011	US20110281864 Pyrido[3,2-d]Pyridazine-2(1H)-One Compounds as p38 Modulators and Methods of Use Thereof
11/17/2011	US20110281857 Pi3k/mtor kinase inhibitors
11/17/2011	US20110281855 Novel and potent tapentadol dosage forms
11/17/2011	US20110281854 Morpholine compounds
11/17/2011	US20110281849 Aryl Indolyl Sulfonamide Compounds and Their Use as 5-HT6 Ligands
11/17/2011	US20110281848 Imidazole compounds having pharmaceutical activity towards the sigma receptor
11/17/2011	US20110281844 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
11/17/2011	US20110281841 Kinase Inhibitors
11/17/2011	US20110281840 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
11/17/2011	US20110281836 Silent desensitizers of neuronal NACHR and methods of use thereof
11/17/2011	US20110281835 Novel 3-phenyl-azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission
11/17/2011	US20110281832 Organic compounds
11/17/2011	US20110281822 Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity
11/17/2011	US20110281811 Use Of Leukotriene Inhibitors For Treating Lung Diseases In Prematurely Born Infants
11/17/2011	US20110281810 Composition
11/17/2011	US20110281808 Composition and Method for Increasing Pre Workout Thermogenics
11/17/2011	US20110281804 Peptidic and peptidomimetic compounds for regulating autophagy
11/17/2011	US20110281794 composition comprising nor-adrenaline and amphetamine for administering to a brain-dead, heart-beating potential organ donor
11/17/2011	US20110281292 Compositions and methods for identifying antigens which elicit an immune response
11/17/2011	US20110281021 Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
11/17/2011	US20110280975 Composition comprising bamboo extract and the compounds isolated therefrom showing activity for the treatment and prevention of inflammatory and blood circulation disease
11/17/2011	US20110280974 Substances Having Body Mass Redistribution Properties
11/17/2011	US20110280951 Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome
11/17/2011	US20110280945 Novel method for the preparation of granulates of active constituents, and granulates as obtained
11/17/2011	US20110280940 Di-Vanilloyl And Tri-Vanilloyl Derivatives For Use In Anti-Cancer Therapy
11/17/2011	US20110280934 Increased Expression of Specific Antigens
11/17/2011	US20110280927 Composition and dressing with nitric oxide
11/17/2011	US20110280885 Cancer immunotherapy
11/17/2011	US20110280879 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies
11/17/2011	US20110280878 Substance specific to human pd-1
11/17/2011	US20110280876 Mutated netrin - 4, fragments thereof and their use as medicines
11/17/2011	US20110280873 MCP1-Ig FUSION VARIANTS
11/17/2011	US20110280871 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/17/2011	US20110280867 Heterocyclic aspartyl protease inhibitors
11/17/2011	US20110280855 Vitamin c compositions
11/17/2011	US20110280852 Nitro fatty acids - neuroprotection and/or inhibition of cognitive decline
11/17/2011	US20110280846 Olfactory epithelial-derived stem cells and methods of use therefor
11/17/2011	US20110280845 Treatment of rheumatoid arthritis using placental stem cells
11/17/2011	US20110280837 Bifidobacterium longum and hippocampal bdnf expression
11/17/2011	US20110280832 Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
11/17/2011	US20110280831 Combinations comprising methotrexate and dhodh inhibitors
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	US20110280808 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-Like Proteins
11/17/2011	US20110280807 Methods and Models for Stress-Induced Analgesia
11/17/2011	US20110280804 Highly selective sigma receptor radioligands
11/17/2011	US20110280800 Il-1 binding proteins
11/17/2011	CA2835596A1 Benzo- or pyrido-imidazole derivative
11/17/2011	CA2800578A1 Nitrogen-heterocyclic compounds as phosphodiesterase 10 inhibitors
11/17/2011	CA2799162A1 Treatment of mci and alzheimer's disease
11/17/2011	CA2799146A1 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
11/17/2011	CA2799020A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
11/17/2011	CA2798874A1 Phenolic compositions derived from apple skin and uses thereof
11/17/2011	CA2798490A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors
11/17/2011	CA2795438A1 Method of detecting and profiling progression of the risk of neurodegenerative diseases
11/16/2011	EP2386575A2 Dual specificity antibodies and methods of making and using
11/16/2011	EP2386566A2 Chi-conotoxin peptides (II)
11/16/2011	EP2386547A1 Multicyclic amino acid derivatives and methods of their use
11/16/2011	EP2386546A1 Novel pyrazole-3-carboxamide derivate having 5-ht2b receptor antagonist activity
11/16/2011	EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors
11/16/2011	EP2386303A1 Eslicarbazepine acetate and methods of use
11/16/2011	EP2385946A1 Derivatives of 6-cycloamino-2,3-di-pyridinyl-imidazo[1,2-b]-pyridazine, preparation and tuerapeutic application thereof
11/16/2011	EP2385943A2 Fluorine containing compounds and methods of use thereof
11/16/2011	EP2385829A1 Pro-neurogenic compounds
11/16/2011	EP2225243B1 Derivatives of N-heterocyclic-6-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
11/16/2011	EP2125785B1 Indole-3-yl-carbonyl-piperidine- derivatives for the treatment of anxiety and depressive disorders via v1a receptor antagonism
11/16/2011	EP2086959B1 Substituted 2-imidazoles as modulators of the trace amine associated receptors
11/16/2011	EP2069334B1 Aspalathin-like dihydrochalcone, extracts from unfermented rooibos and process for preparation
11/16/2011	EP1931676B1 Pyrazolopyrimidines as protein kinase inhibitors
11/16/2011	EP1727794B1 Novel benzyl(idene)-lactam derivatives
11/16/2011	EP1696904B1 Use of rotigotine for the treatment or prevention of dopaminergic neurone loss
11/16/2011	EP1542657B1 Cannabinoid liquid formulations for mucosal amdinistration
11/16/2011	EP1506166B1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/16/2011	CN1741791B A composition material for transmucosal delivery
11/16/2011	CN1612941B Methods of treating psychosis and schizophrenia based on polymorphisms in the CNTF gene
11/16/2011	CN102245629A Modified amyloid beta peptide
11/16/2011	CN102245614A Methylene amines of thieno [2, 3-d] pyrimidine and their use as adenosine A2a receptor antagonists
11/16/2011	CN102245613A Phenyl and heteroaryl substituted thieno[2, 3-d] pyrimidines and their use as adenosine A2a receptor antagonists
11/16/2011	CN102245573A Heteroaryl derivatives as cftr modulators
11/16/2011	CN102245181A Heterocyclic benzimidazoles as TRPM8 modulators
11/16/2011	CN102245180A Compositions and methods for the treatment of altered alpha-synuclein function
11/16/2011	CN102245179A Therapeutics for neurological disorders
11/16/2011	CN102245167A Formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules
11/16/2011	CN102242154A Liquid fermentation method for producing paecilomyces cicadae mycelia and application of culture product
11/16/2011	CN102242117A Aquaporin 4-siRNA interfering sequence, its fusion expression vectors and medicinal use of the fusion expression vectors
11/16/2011	CN102242070A Method for artificially culturing paecilomyces cicadae and application of culturing product thereof
11/16/2011	CN102242069A Paecilomycescicadae (Miq.)Samson and application thereof
11/16/2011	CN102241710A Salidroside analogues as well as preparation method and application thereof
11/16/2011	CN102241680A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
11/16/2011	CN102241678A Antitumor effect and application of alicyclic structure-containing compound
11/16/2011	CN102241667A 1-[(4-hydroxypiperidine-4-yl) methyl] pyridine-2(1H)-one derivatives, preparation method and use thereof
11/16/2011	CN102241664A Aralkyl diamine derivatives and use thereof as antidepressants
11/16/2011	CN102241657A Synthesis of isoflavone compound through Stille crossed coupling reaction
11/16/2011	CN102241646A Hexenone compound, and medical purpose thereof
11/16/2011	CN102241621A 5,5-disubstituted-2-iminopyrrolidine derivatives, preparation method thereof, and medical applications thereof
11/16/2011	CN102241608A Retigabine compound and composition thereof
11/16/2011	CN102241596A O-aminoalcohol compounds, preparation method thereof and application thereof
11/16/2011	CN102240397A Production of high mannose proteins in plant culture
11/16/2011	CN102240391A Traditional Chinese medicine solution for health promotion
11/16/2011	CN102240388A Ginger extract and preparation method and applications thereof
11/16/2011	CN102240387A Traditional Chinese medicine for relieving alcoholism

1 ... 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 ... 1833